Ruti Aga: Six Years, and a Forged Prescription That Ended a Career

September 10. From that date, two years, then four — six in total. The cleanest number in the Ruti Aga file is not 2:18:34. It is six.

The Athletics Integrity Unit has banned the 32-year-old Ethiopian marathoner for six years, counted from September 10 — the same date her provisional suspension began. When the ban expires she will be 38. Anyone who has watched the depth of Ethiopian women's marathoning knows that a 38-year-old with a doping record on file does not get the national vest back. This is not a return. It is an entry ban.

In March she won a half marathon in China. The race name, the time, the quality of the field — none of it is public. The sample was collected there. It contained methylprednisolone.

That is where the first jolt arrives, and it is a jolt about the reporting, not the substance.

In my Hyderabad ledger, Aga's first entry is Berlin 2026 — 2:18:34, second place. Tokyo 2026, 2:20:40, first. Those numbers come from my own archive, not from the AIU statement; the statement does not mention them at all. That is my complaint. In a case where the entire sanction arithmetic rests on the in-competition window and the timing of the sample, the statement gives no race time, no date, not even a year. The ledger said one thing. The season said another. I wrote down both, and the gap between them.

Context: why two years plus four

The Code's arithmetic is straightforward. Two years for presence — a prohibited substance found in the body. Four years for tampering — misleading documents or statements during the investigation. Total, six. The architecture is standard, not exceptional. What is exceptional is that six years landed on a substance that offers no proven endurance benefit.

This is where most of the coverage got it wrong. Reports called methylprednisolone a "prohibited steroid." That is technically incorrect. Methylprednisolone is a glucocorticoid, class S9 on the WADA Prohibited List, not an anabolic steroid (S1). And S9 carries a different condition: prohibited in-competition only, and only by injection, oral or rectal route. An intra-articular injection for knee synovitis is ordinary sports-medicine practice in distance runners, entirely legal out of competition.

Which means the whole case rested not on "steroid use" but on route and timing. A road race's testing window opens at 23:59 the night before the race, so an injection given days earlier is caught. That was the only technical door left open.

Core: the defence that was destroyed from the inside

According to the AIU statement, Aga cited a knee injury and produced a prescription for the treatment. Three things broke, independently. One, the clinic on the prescription did not exist. Two, the person who wrote it was a family member with no medical registration. Three, that person claimed to have used "an old prescription pad from a former workplace" — a clinic that disowns the claim in plain terms.

Three independent verification failures, all on one document. This is not a filing error. It is the signature of an athlete operating without a credentialed team physician.

Here is the bitter part. Had the knee treatment been real and the records genuine, a defence existed — medical necessity, route, sufficient washout before competition. Cases of that shape routinely end in a reprimand or a heavily reduced period, with no tampering charge at all. By manufacturing the prescription, Aga cut the one defensive line that could have held. The panel did not accept a no-significant-fault mitigation; the 2+4 sum is the proof. The presence sanction was not extended, but neither was it reduced.

Record this too: the 2026 Tokyo title and three World Marathon Majors second places do not annul themselves. The violation is anchored to the March race; results before that date stay in the book absent evidence of earlier use. The statement does not specify the disqualification scope. In my experience the AIU automatically voids the competition where the sample was collected, plus prize money — here, the Chinese race.

Contrarian: six years for a substance that does not help

The easy verdict is that a cheat was caught, punished, file closed. I will not write that verdict, because the documents say something else.

The sanction is for the paper, not the substance. Four of the six years exist because a prescription was fake. Set that against anabolic-steroid cases, where direct performance gain is established, and this penalty sits heavier. That is not an argument to excuse Aga; it is a question about whether the enforcement frontier has shifted from substances to paperwork.

The second point is that the root of the episode is a knee, not a prescription. Chronic knee pathology is a known load-bearing failure mode in high-volume marathoners. Stopping racing while injured means stopping appearance-fee income. Glucocorticoids are the cheapest, most available tool for masking that pain. And when there is no team physician, treatment migrates inside the family — and that is where documents start getting made. This is causal analysis, not sympathy. The accountability is hers, because the forged paper moved through her hands.

Third, and Indian readers tend to skip this: the AIU's work here was fast and clean — three verifications, one statement, one arithmetic. Credit the investigators who established that the clinic did not exist. Note also that no Ethiopian federation statement is quoted. Where a national federation stays silent, the athlete stands alone; and an athlete standing alone fabricates paper.

Takeaway: the next frontier

I opened an anomaly file in 2026. It has never been closed. I am not filing this case inside it — its date, its substance, its document are different, and they will stay different.

What to watch is that AIU enforcement is moving from detection to verification. Finding a sample is getting easier; the hard part is establishing whether the paper placed in front of you is real. China's label-race circuit — large appearance-fee budgets, deep East African fields, AIU testers — is now a high-scrutiny zone. The informal medical networks that surrounded Aga serve dozens of other runners in the same training clusters. More of these cases are in the pipeline.

Every number arrives with a witness. In this case the witness was a clinic that never existed. My job was to go find it. Found.